JP2025502205A - 設計されたサイトカイン組成物および使用方法 - Google Patents

設計されたサイトカイン組成物および使用方法 Download PDF

Info

Publication number
JP2025502205A
JP2025502205A JP2024541803A JP2024541803A JP2025502205A JP 2025502205 A JP2025502205 A JP 2025502205A JP 2024541803 A JP2024541803 A JP 2024541803A JP 2024541803 A JP2024541803 A JP 2024541803A JP 2025502205 A JP2025502205 A JP 2025502205A
Authority
JP
Japan
Prior art keywords
cytokine
cell
designed
polypeptide
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024541803A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025502205A5 (https=
Inventor
ボイケン，スコット
ラジョイ，マーク
ダベンポート，サデュエス・エム
モフェット，ハウエル
ウェイツナー，ブライアン
ヌ，アンドリュー・ホーウェン
サンプル，ポール・ジョセフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Outpace Bio Inc
Original Assignee
Outpace Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Outpace Bio Inc filed Critical Outpace Bio Inc
Publication of JP2025502205A publication Critical patent/JP2025502205A/ja
Publication of JP2025502205A5 publication Critical patent/JP2025502205A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5443—IL-15
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2024541803A 2022-01-11 2023-01-11 設計されたサイトカイン組成物および使用方法 Pending JP2025502205A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202263298623P 2022-01-11 2022-01-11
US63/298,623 2022-01-11
US202363479178P 2023-01-09 2023-01-09
US202363479177P 2023-01-09 2023-01-09
US202363479176P 2023-01-09 2023-01-09
US63/479,177 2023-01-09
US63/479,176 2023-01-09
US63/479,178 2023-01-09
PCT/US2023/060508 WO2023137346A2 (en) 2022-01-11 2023-01-11 Designed cytokine compositions and methods of use

Publications (2)

Publication Number Publication Date
JP2025502205A true JP2025502205A (ja) 2025-01-24
JP2025502205A5 JP2025502205A5 (https=) 2026-01-21

Family

ID=87279672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024541803A Pending JP2025502205A (ja) 2022-01-11 2023-01-11 設計されたサイトカイン組成物および使用方法

Country Status (10)

Country Link
US (1) US20250223330A1 (https=)
EP (1) EP4463469A4 (https=)
JP (1) JP2025502205A (https=)
KR (1) KR20240164594A (https=)
CN (1) CN119053616A (https=)
AU (1) AU2023208031A1 (https=)
CA (1) CA3248134A1 (https=)
IL (1) IL314226A (https=)
MX (1) MX2024008642A (https=)
WO (1) WO2023137346A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL325764A (en) * 2023-07-13 2026-03-01 Outpace Bio Inc Designed compositions of interleukin-2 cytokine and methods of use
WO2025212606A1 (en) * 2024-04-01 2025-10-09 Bio-Techne Corporation Synthetic il-2 polypeptides and conjugates, compositions, and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210025522A (ko) * 2018-06-25 2021-03-09 유니버시티 오브 워싱톤 강력하고 선택적인 인터루킨 모방체의 드 노보 디자인
MX2021000801A (es) * 2018-07-24 2021-04-12 BioNTech SE Agonistas de il2.
CN118510795A (zh) * 2022-01-07 2024-08-16 苏州克睿基因生物科技有限公司 新型白介素-2多肽

Also Published As

Publication number Publication date
US20250223330A1 (en) 2025-07-10
KR20240164594A (ko) 2024-11-19
IL314226A (en) 2024-09-01
CA3248134A1 (en) 2023-07-20
MX2024008642A (es) 2024-09-23
EP4463469A2 (en) 2024-11-20
AU2023208031A1 (en) 2024-08-29
EP4463469A4 (en) 2026-01-14
WO2023137346A2 (en) 2023-07-20
CN119053616A (zh) 2024-11-29
WO2023137346A3 (en) 2023-11-16

Similar Documents

Publication Publication Date Title
US20240374645A1 (en) Biologically relevant orthogonal cytokine/receptor pairs
JP6783797B2 (ja) 抗がん融合ポリペプチド
KR102653906B1 (ko) 편향된 il2 뮤테인 방법 및 조성물
AU2020346824B2 (en) Chimeric orthogonal receptor proteins and methods of use
CN117836318A (zh) 用于降解靶蛋白的双特异性结合剂-配体融合物
CN111511911A (zh) 表达特异性地识别人间皮素的细胞表面分子、il-7和ccl19的免疫活性细胞
CN109652379A (zh) Cd7嵌合抗原受体修饰的nk-92mi细胞及其应用
JP2025502205A (ja) 設計されたサイトカイン組成物および使用方法
KR20220131529A (ko) 변경된 icd stat 신호전달을 갖는 cd122
TW202140537A (zh) 針對含有ｇ１２ｖ突變之ｒａｓ之ｈｌａ第ｉｉ類限制性ｔ細胞受體
WO2025015322A1 (en) Designed interleukin-2 cytokine compositions and methods for use
JP5012926B2 (ja) Ｉｌ−６レセプター・ｉｌ−６直結融合蛋白質
TW202525858A (zh) 抗間皮素嵌合抗原受體及使用方法
US20240293456A1 (en) Combinations of small molecule drug conjugate and car-expressing cytotoxic lymphocytes and methods of treating cancer using the same
CN113603791A (zh) 一种融合蛋白及其应用
US20250319131A1 (en) Tunable cytokine receptor signaling domains
US20250250329A1 (en) Cytokine adaptor proteins and uses thereof
JP4524816B2 (ja) Ｉｌ−６レセプター・ｉｌ−６直結融合蛋白質
WO2025207624A1 (en) Compositions and methods useful in the treatment of autoimmune disease
TW202434618A (zh) 經設計之細胞激素組合物及使用方法
CN120842359A (zh) 白介素-15突变体及其用途
CN116731193A (zh) 重组蛋白及其应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260113

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260113